XML 46 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
WARRANTS
3 Months Ended
Mar. 31, 2014
Notes to Financial Statements  
Note 12. WARRANTS

The Company uses valuation methods and assumptions that consider among other factors the fair value of the underlying stock, risk-free interest rate, volatility, expected life and dividend rates in estimating fair value for the warrants considered to be derivative instruments.  The following assumptions were utilized by the Company:

 

    2014     2013  
Risk-free interest rate     1.53% - 1.73 %     0.70% - 2.23 %
Expected dividend yield            
Expected term (contractual term)   3.42 – 5 years     0.06 - 5 years  
Forfeiture rate            
Expected volatility     121% - 122 %     123% - 144 %

 

Expected volatilities are based on historical volatility of the Common Stock using historical periods consistent with the expected term of the warrant. The risk-free rate is based on the yield of a U.S. Treasury security with a term consistent with the warrant.

 

In the three months ended March 31, 2014, the Company issued 18,182 warrants in connection with a partial closing related to the private placement of the Company’s Common Stock with MTIA (See Note 8).

 

At March 31, 2014, the Company had the following outstanding warrants:

 

   

Number of

Shares

Exercisable

    Exercise Price   Date of Expiration
Outstanding warrants accounted for as derivative warrant liability:              
Granted to debt holder     400,000     $ 20.00   8/31/2017
Granted to debt holder     100,000       21.30   9/20/2017
Granted to debt holder     50,000       22.70   10/17/2017
Granted to debt holder     150,000       21.10   11/6/2017
Total outstanding warrants accounted for as derivative warrant liability     700,000            
Weighted average exercise price           $ 20.61    
Weighted average time to expiration                 3.48 years
                   
Outstanding warrants accounted for as equity:                  
Granted to investors in private placement     40,000       15.90   6/30/2014
Granted to investors in private placement     76,800       20.00   11/13/2014
Granted to placement agent in private placement     25,695       15.00   11/13/2014
Granted to investors in private placement     6,300       20.00   12/3/2014
Granted to investors in private placement     34,147       22.50   2/9/2015
Granted to placement agents in private placement     2,853       22.50   2/9/2015
Granted to investor in private placement     638       22.50   3/18/2015
Granted to investors in private placement     95,960       30.00   12/7/2014
Granted to investors in private placement of common and preferred stock     181,818       2.75   12/10/2018
Granted to investors in private placement of common stock     18,182       2.75   2/20/2019
Total outstanding warrants accounted for as equity     482,393            
Weighted average exercise price           $ 14.43    
Weighted average time to expiration                 2.14 years
                   
Totals for all warrants outstanding:                  
Total     1,182,393            
Weighted average exercise price           $ 18.09    
Weighted average time to expiration                 3.01 years

 

A summary of warrant activity for the three months ended March 31, 2014 is as follows:

 

Warrants   Shares     Weighted- Average Exercise Price  
Outstanding warrants at January 1, 2014     1,209,211     $ 17.92  
Granted     18,182     $ 2.75  
Exercised         $  
Forfeited or expired     (45,000 )   $ 7.30  
Outstanding warrants at March 31, 2014     1,182,393     $ 18.09